Difference between revisions of "LncRNAWiki:N"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''N4BP2L2-IT2'' |N4BP2L2-IT2 |CG030 |N4BPL2 intronic trans...") |
|||
Line 1: | Line 1: | ||
+ | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
+ | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
+ | </div> | ||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
Line 5: | Line 8: | ||
!Alias | !Alias | ||
!Description | !Description | ||
+ | !Disease | ||
|- | |- | ||
|''N4BP2L2-IT2'' | |''N4BP2L2-IT2'' | ||
Line 10: | Line 14: | ||
|CG030 | |CG030 | ||
|N4BPL2 intronic transcript 2 | |N4BPL2 intronic transcript 2 | ||
+ | |_ | ||
|- | |- | ||
|''NALT1'' | |''NALT1'' | ||
Line 15: | Line 20: | ||
|TCONSN/Al2N/A00029132 | |TCONSN/Al2N/A00029132 | ||
|NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1 | |NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1 | ||
+ | |_ | ||
|- | |- | ||
|''NAMA'' | |''NAMA'' | ||
|[[ENST00000604258.1]] | |[[ENST00000604258.1]] | ||
|N/A | |N/A | ||
− | |non-protein coding RNA, associated with MAP kinase pathway and growth arrest | + | |"non-protein coding RNA, associated with MAP kinase pathway and growth arrest" |
+ | |papillary thyroid carcinoma | ||
|- | |- | ||
|''NBAT1'' | |''NBAT1'' | ||
Line 25: | Line 32: | ||
|NBAT-1 | |NBAT-1 | ||
|neuroblastoma associated transcript 1 | |neuroblastoma associated transcript 1 | ||
+ | |Fighting Neuroblastomas ;breast cancer | ||
|- | |- | ||
|''NBR2'' | |''NBR2'' | ||
Line 30: | Line 38: | ||
|NCRNA00192 | |NCRNA00192 | ||
|neighbor of BRCA1 gene 2 (non-protein coding) | |neighbor of BRCA1 gene 2 (non-protein coding) | ||
+ | |breast cancer | ||
|- | |- | ||
|''NCBP2-AS2'' | |''NCBP2-AS2'' | ||
Line 35: | Line 44: | ||
|N/A | |N/A | ||
|NCBP2 antisense RNA 2 (head to head) | |NCBP2 antisense RNA 2 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''NCOA7-AS1'' | |''NCOA7-AS1'' | ||
Line 40: | Line 50: | ||
|N/A | |N/A | ||
|NCOA7 antisense RNA 1 | |NCOA7 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''ncR-PAR'' | |''ncR-PAR'' | ||
|[[NONHSAT102247]] | |[[NONHSAT102247]] | ||
− | |NCRUPAR, ENSG00000225407 | + | |"NCRUPAR, ENSG00000225407" |
− | |non-protein coding RNA, upstream of F2R/PAR1 | + | |"non-protein coding RNA, upstream of F2R/PAR1" |
+ | |_ | ||
|- | |- | ||
|''NCRUPAR'' | |''NCRUPAR'' | ||
|[[NCRUPAR]] | |[[NCRUPAR]] | ||
− | |ncR-uPAR, ncRuPAR, NCRNA00193 | + | |"ncR-uPAR, ncRuPAR, NCRNA00193" |
− | |non-protein coding RNA, upstream of F2R/PAR1 | + | |"non-protein coding RNA, upstream of F2R/PAR1" |
+ | |_ | ||
|- | |- | ||
|''NDM29'' | |''NDM29'' | ||
|[[lnc-C11orf16-1:1]] | |[[lnc-C11orf16-1:1]] | ||
|29A | |29A | ||
− | |neuroblastoma differentiation marker 29 (Castelnuovo (2010), | + | |"neuroblastoma differentiation marker 29 (Castelnuovo (2010), Pagano (2007))." |
+ | |neuroblastoma | ||
|- | |- | ||
|''NEAT1'' | |''NEAT1'' | ||
|[[ENST00000501122.2]],[[NONHSAT022111]] | |[[ENST00000501122.2]],[[NONHSAT022111]] | ||
− | |MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532 | + | |"MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532" |
|Nuclear enriched abundant transcript 1. | |Nuclear enriched abundant transcript 1. | ||
+ | |infertility | ||
|- | |- | ||
|''NFIA-AS1'' | |''NFIA-AS1'' | ||
Line 65: | Line 80: | ||
|RP5-833A20.1 | |RP5-833A20.1 | ||
|NFIA antisense RNA 1 | |NFIA antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''NIPBL-AS1'' | |''NIPBL-AS1'' | ||
Line 70: | Line 86: | ||
|NIPBL-AS | |NIPBL-AS | ||
|NIPBL antisense RNA 1 (head to head) | |NIPBL antisense RNA 1 (head to head) | ||
+ | |autism spectrum disorders | ||
|- | |- | ||
|''NKILA'' | |''NKILA'' | ||
Line 75: | Line 92: | ||
|N/A | |N/A | ||
|NF-kappaB interacting long non-coding RNA | |NF-kappaB interacting long non-coding RNA | ||
+ | |breast cancer | ||
|- | |- | ||
|''NKX2-2-AS1'' | |''NKX2-2-AS1'' | ||
Line 80: | Line 98: | ||
|NKX2-2AS | |NKX2-2AS | ||
|NKX2-2 antisense RNA 1 | |NKX2-2 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''NOP14-AS1'' | |''NOP14-AS1'' | ||
Line 85: | Line 104: | ||
|RES4-24 | |RES4-24 | ||
|NOP14 antisense RNA 1 | |NOP14 antisense RNA 1 | ||
+ | |Huntington disease | ||
|- | |- | ||
|''NORAD'' | |''NORAD'' | ||
Line 90: | Line 110: | ||
|N/A | |N/A | ||
|non-coding RNA activated by DNA damage | |non-coding RNA activated by DNA damage | ||
+ | |_ | ||
|- | |- | ||
|''NPHP3-AS1'' | |''NPHP3-AS1'' | ||
Line 95: | Line 116: | ||
|N/A | |N/A | ||
|NPHP3 antisense RNA 1 | |NPHP3 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''NPPA-AS1'' | |''NPPA-AS1'' | ||
Line 100: | Line 122: | ||
|N/A | |N/A | ||
|NPPA antisense RNA 1 | |NPPA antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''NPSR1-AS1'' | |''NPSR1-AS1'' | ||
|[[NPSR1-AS1]] | |[[NPSR1-AS1]] | ||
− | |AAA1, IMAGE:4827585 | + | |"AAA1, IMAGE:4827585" |
|NPSR1 antisense RNA 1 | |NPSR1 antisense RNA 1 | ||
+ | |cardiovascular disease | ||
|- | |- | ||
|''NPTN-IT1'' | |''NPTN-IT1'' | ||
Line 110: | Line 134: | ||
|lncRNA-LET | |lncRNA-LET | ||
|NPTN intronic transcript 1 | |NPTN intronic transcript 1 | ||
+ | |colorectal cancer; hepatocelluar carcinoma;squamous-cell lung carcinomas | ||
|- | |- | ||
|''NR2F1-AS1'' | |''NR2F1-AS1'' | ||
Line 115: | Line 140: | ||
|FLJ42709 | |FLJ42709 | ||
|NR2F1 antisense RNA 1 | |NR2F1 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''NRAV'' | |''NRAV'' | ||
Line 120: | Line 146: | ||
|N/A | |N/A | ||
|negative regulator of antiviral response (non-protein coding) | |negative regulator of antiviral response (non-protein coding) | ||
+ | |influenza A virus (IAV) infection | ||
|- | |- | ||
|''NRIR'' | |''NRIR'' | ||
Line 125: | Line 152: | ||
|lncRNA-CMPK2 | |lncRNA-CMPK2 | ||
|negative regulator of interferon response (non-protein coding) | |negative regulator of interferon response (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''NRON'' | |''NRON'' | ||
|[[NONHSAT134764]] | |[[NONHSAT134764]] | ||
|ENSG00000253079 | |ENSG00000253079 | ||
− | |non-protein coding RNA, repressor of NFAT | + | |"non-protein coding RNA, repressor of NFAT" |
+ | |AIDS | ||
|- | |- | ||
|''NTT'' | |''NTT'' | ||
|[[NONHSAT115106]] | |[[NONHSAT115106]] | ||
− | | | + | | |
|noncoding transcript in T cells. | |noncoding transcript in T cells. | ||
+ | |_ | ||
+ | |- | ||
|} | |} |
Revision as of 11:38, 30 June 2016
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
N4BP2L2-IT2 | N4BP2L2-IT2 | CG030 | N4BPL2 intronic transcript 2 | _ |
NALT1 | NALT1 | TCONSN/Al2N/A00029132 | NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1 | _ |
NAMA | ENST00000604258.1 | N/A | "non-protein coding RNA, associated with MAP kinase pathway and growth arrest" | papillary thyroid carcinoma |
NBAT1 | NBAT1 | NBAT-1 | neuroblastoma associated transcript 1 | Fighting Neuroblastomas ;breast cancer |
NBR2 | NBR2 | NCRNA00192 | neighbor of BRCA1 gene 2 (non-protein coding) | breast cancer |
NCBP2-AS2 | NCBP2-AS2 | N/A | NCBP2 antisense RNA 2 (head to head) | _ |
NCOA7-AS1 | NCOA7-AS1 | N/A | NCOA7 antisense RNA 1 | _ |
ncR-PAR | NONHSAT102247 | "NCRUPAR, ENSG00000225407" | "non-protein coding RNA, upstream of F2R/PAR1" | _ |
NCRUPAR | NCRUPAR | "ncR-uPAR, ncRuPAR, NCRNA00193" | "non-protein coding RNA, upstream of F2R/PAR1" | _ |
NDM29 | lnc-C11orf16-1:1 | 29A | "neuroblastoma differentiation marker 29 (Castelnuovo (2010), Pagano (2007))." | neuroblastoma |
NEAT1 | ENST00000501122.2,NONHSAT022111 | "MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532" | Nuclear enriched abundant transcript 1. | infertility |
NFIA-AS1 | NFIA-AS1 | RP5-833A20.1 | NFIA antisense RNA 1 | _ |
NIPBL-AS1 | NIPBL-AS1 | NIPBL-AS | NIPBL antisense RNA 1 (head to head) | autism spectrum disorders |
NKILA | NKILA | N/A | NF-kappaB interacting long non-coding RNA | breast cancer |
NKX2-2-AS1 | NKX2-2-AS1 | NKX2-2AS | NKX2-2 antisense RNA 1 | _ |
NOP14-AS1 | NOP14-AS1 | RES4-24 | NOP14 antisense RNA 1 | Huntington disease |
NORAD | NORAD | N/A | non-coding RNA activated by DNA damage | _ |
NPHP3-AS1 | NPHP3-AS1 | N/A | NPHP3 antisense RNA 1 | _ |
NPPA-AS1 | NPPA-AS1 | N/A | NPPA antisense RNA 1 | _ |
NPSR1-AS1 | NPSR1-AS1 | "AAA1, IMAGE:4827585" | NPSR1 antisense RNA 1 | cardiovascular disease |
NPTN-IT1 | NPTN-IT1 | lncRNA-LET | NPTN intronic transcript 1 | colorectal cancer; hepatocelluar carcinoma;squamous-cell lung carcinomas |
NR2F1-AS1 | NR2F1-AS1 | FLJ42709 | NR2F1 antisense RNA 1 | _ |
NRAV | NRAV | N/A | negative regulator of antiviral response (non-protein coding) | influenza A virus (IAV) infection |
NRIR | ENST00000414795.1 | lncRNA-CMPK2 | negative regulator of interferon response (non-protein coding) | _ |
NRON | NONHSAT134764 | ENSG00000253079 | "non-protein coding RNA, repressor of NFAT" | AIDS |
NTT | NONHSAT115106 | noncoding transcript in T cells. | _ |